MEDP Medpace Holdings, Inc.

CIK 0001668397 15 ready 8-Ks latest April 22, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 15

Latest filing May 19, 2026, 2:43 PM ET

Top materiality 0.70

Event mix other_material ×6 · earnings ×5 · leadership ×2

Sentiment 2 pos · 0 neg · 13 neu

Latest earnings reported 2025-FY

Executive change recent →

Recent 8-K filings for MEDP

Highest-materiality recent filing

Medpace increases buyback by $1.0B, expands credit line to $600M; Q1 results released without specifics

April 21, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 2.02 item 8.01 item 9.01

Board approved $1.0B increase to stock repurchase program; timing based on market conditions.
Credit facility amended: line raised to $600M, interest rate adjusted, expiration extended to April 30, 2027.

Read filing →

April 22, 2026, 7:59 PM ET leadership materiality 0.60 neutral item 2.02 item 5.02 item 9.01 ◈ Earnings Releases

President Jesse Geiger resigns; CEO Troendle to reassume role; Q1 earnings results not available in filing

Jesse Geiger to resign as President effective May 31, 2026; not due to disagreement.
April 21, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 2.02 item 8.01 item 9.01

Medpace increases buyback by $1.0B, expands credit line to $600M; Q1 results released without specifics

Board approved $1.0B increase to stock repurchase program; timing based on market conditions.
May 21, 2024, 7:59 PM ET other material materiality 0.60 positive item 5.03 item 5.07 item 9.01

Medpace shareholders approve board declassification; annual director elections start 2025

Stockholders approved amendment to phase out classified board; directors elected annually beginning at 2025 annual meeting.

Executive changes

Departed

Ashley M. Keating

Director

MEDP · Medpace Holdings, Inc.

Effective: 2024-06-30
Successor: Dani S. Zander
Filed: July 3, 2024, 7:59 PM ET

On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.

Appointed

Dani S. Zander

Director

MEDP · Medpace Holdings, Inc.

Effective: 2024-07-01
Filed: July 3, 2024, 7:59 PM ET

The Board of the Company following a recommendation from the independent directors of the Board, unanimously approved that Dr. Dani S. Zander be elected to fill the Class III director vacancy on the Board of the Company, effective July 1, 2024

Earnings & guidance

2025-FY EPS reported $15.28 filing →

Materiality & sentiment trend

Max materiality 0.70 · Median 0.50 · Most common event other_material

2 positive 0 negative 13 neutral

source · MEDP on sec.gov